Smoking status on outcomes after percutaneous coronary intervention

Clinical Cardiology

Volumn 35, Issue 9, 2012, Pages 570-574

  Chen, Tao ^a   Li, Wei ^a   Wang, Yang ^a   Xu, Bo ^a   Guo, Jin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; SELF REPORT; SMOKING CESSATION; SMOKING HABIT; TREATMENT OUTCOME;

AGED; COMORBIDITY; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETREATMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866242081     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22004     Document Type: Review

References (28)

1. Gao RL., Current status and perspective of percutaneous coronary intervention in China. Chin Med J (Engl). 2006; 119: 531-532.
2. Woo JS, Kim W, Ha SJ, et al. Impact of gender differences on long-term outcomes after successful percutaneous coronary intervention in patients with acute myocardial infarction. Int J Cardiol. 2010; 145: 516-518.
3. Gaglia MA Jr, Steinberg DH, Pinto Slottow TL, et al. Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2009; 103: 653-658.
4. Rathore S, Rhys J, Buchalter MB, et al. Impact of age on the outcomes of women following percutaneous coronary intervention in the bare-metal stent era. J Interv Cardiol. 2006; 19: 245-249.
5. Blake GJ, Ridker PM., C-reactive protein and prognosis after percutaneous coronary intervention. Eur Heart J. 2002; 23: 923-925.
6. Jensen LO, Maeng M, Thayssen P, et al. Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark. Am J Cardiol. 2010; 105: 1513-1519.
7. Hasdai D, Garratt KN, Grill DE, et al. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med. 1997; 336: 755-761.
8. Ishikawa T, Yagi H, Ogawa T, et al. Deteriorative effect of smoking on target lesion revascularization after implantation of coronary stents with diameter of 3.0 mm or less. Circ J. 2005; 69: 227-231.
9. Taira DA, Seto TB, Ho KK, et al. Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation. 2000; 102: 1369-1374.
10. Haddock CK, Poston WS, Taylor JE, et al. Smoking and health outcomes after percutaneous coronary intervention. Am Heart J. 2003; 145: 652-657.
11. Cohen DJ, Doucet M, Cutlip DE, et al. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox? Circulation. 2001; 104: 773-778.
12. Sherif MA, Nienaber CA, Toelg R, et al. Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE). Clin Res Cardiol. 2011; 100: 413-423.
13. Rea TD, Heckbert SR, Kaplan RC, et al. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med. 2002; 137: 494-500.
14. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005; 142: 233-239.
15. van Domburg RT, Meeter K, van Berkel DF, et al. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol. 2000; 36: 878-883.
16. Critchley JA, Capewell S., Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003; 290: 86-97.
17. van Berkel TF, Boersma H, Roos-Hesselink JW, et al. Impact of smoking cessation and smoking interventions in patients with coronary heart disease. Eur Heart J. 1999; 20: 1773-1782.
18. Gerber Y, Rosen LJ, Goldbourt U, et al. Smoking status and long-term survival after first acute myocardial infarction a population-based cohort study. J Am Coll Cardiol. 2009; 54: 2382-2387.
19. Bjartveit K, Tverdal A., Health consequences of smoking 1-4 cigarettes per day. Tob Control. 2005; 14: 315-320.
20. Frey P, Waters DD, DeMicco DA, et al. Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials). Am J Cardiol. 2011; 107: 145-150.
21. Andrikopoulos GK, Richter DJ, Dilaveris PE, et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's paradox" in a countrywide study. Eur Heart J. 2001; 22: 776-784.
22. Weisz G, Cox DA, Garcia E, et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction-the smoker's paradox revisited. Am Heart J. 2005; 150: 358-364.
23. Aygul N, Ozdemir K, Abaci A, et al. Comparison of traditional risk factors, angiographic findings, and in-hospital mortality between smoking and nonsmoking Turkish men and women with acute myocardial infarction. Clin Cardiol. 2010; 33: E49-E54.
24. Andrikopoulos GK, Chimonas ET, Toutouzas PK., Paradoxical clinical value of another smoker's paradox. Circulation. 2002; 105: e55.
25. Katayama T, Iwasaki Y, Sakoda N, et al. The etiology of 'smoker's paradox' in acute myocardial infarction with special emphasis on the association with inflammation. Int Heart J. 2008; 49: 13-24.
26. Barbash GI, White HD, Modan M, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation. 1993; 87: 53-58.
27. Herlitz J, Karlson BW, Sjolin M, et al. Five-year mortality in patients with acute chest pain in relation to smoking habits. Clin Cardiol. 2000; 23: 84-90.
28. Yun AJ, Bazar KA, Lee PY, et al. The smoking gun: many conditions associated with tobacco exposure may be attributable to paradoxical compensatory autonomic responses to nicotine. Med Hypotheses. 2005; 64: 1073-1079.